Summary

The healthcare information exchange (HIE) market is projected to reach USD 3.40 billion by 2031 from USD 2.09 billion in 2026, at a CAGR of 10.3% from 2026 to 2031. This market expansion is primarily driven by the need for seamless exchanges of patient health information within the healthcare environment. As healthcare delivery becomes increasingly fragmented, with patients seeking medical attention from multiple providers, there is a growing demand for coordinated and consistent services. Additionally, regulatory policies, government initiatives, and programs designed to promote interoperability and information exchange have contributed to the adoption of HIE solutions. Notable examples of these initiatives include the MACRA legislation and the Promoting Interoperability program (formerly known as Meaningful Use), which offer incentives for adopting electronic health record (EHR) technologies that incorporate HIE capabilities. However, the market faces challenges due to the lack of standardized data formats and interoperability between incompatible systems.

https://mnmimg.marketsandmarkets.com/Images/healthcare-information-exchange-market-img-overview.webp

“By solution, the platform-centric HIE solutions segment is expected to witness the highest growth during the forecast period.”
The health information exchange (HIE) market is divided into three segments: portal-centric, messaging-centric, and platform-centric. Among these, the platform-centric solutions segment is expected to grow the fastest. This growth is driven by an increasing need for cloud-enabled ecosystems that facilitate data sharing and interoperability among healthcare stakeholders. Platform-centric solutions encompass integrated platforms that combine data exchange, analytics, and applications, enhancing both operational efficiency and decision-making. One example of a company in this space is Veradigm, which offers data platforms that promote interoperability using FHIR standards and enable real-time data exchange among various industry stakeholders.

“By application, the web portal development segment held the largest market share in 2025.”
The health information exchange market is segmented based on application into web portal development, workflow management, secure messaging, internal interfacing, and other applications. The web portal development segment held the largest market share in 2025 due to its crucial role in providing easy access to patient health data for both medical professionals and patients. Web portals serve as central hubs where users can access, share, and organize their health data, including test results, drug profiles, and other health-related information. A key factor contributing to the success of the web portal development category is its widespread use by hospitals of all sizes and types. This accessibility allows doctors to quickly obtain patient health data from various sources, including electronic health record (EHR) systems, lab data, and imaging systems.

“By end user, the healthcare providers segment is expected to register the highest growth in the health information exchange market during the forecast period.”
The health information exchange (HIE) market is segmented by end user into three categories: healthcare providers, healthcare payers, and pharmacies. The healthcare providers segment is experiencing the fastest growth due to its vital role in delivering care and managing patient medical records. In the US, healthcare providers are increasingly focusing on implementing HIE solutions to enhance care coordination and ensure regulatory compliance. For example, in June 2023, the prominent healthcare provider, Mayo Clinic, announced a strategic alliance with Microsoft to launch the Azure Health Data Services platform. This platform is equipped with HIE functionality, enabling seamless data exchange across the organization's facilities.

“The APAC is estimated to register the highest CAGR during the forecast period.”
This report segments the healthcare information exchange (HIE) market into several regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The HIE market in the Asia Pacific (APAC) region is projected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth is largely due to significant transformations in the APAC healthcare landscape, characterized by increased digitization, urbanization, and higher healthcare spending. As more healthcare organizations adopt technological innovations to enhance their services, the necessity for data exchange and interoperability is becoming more evident. Additionally, government policies and programs aimed at promoting the use of IT solutions and interoperability in the healthcare sector are further driving the HIE market in the APAC region. Countries such as China, Japan, South Korea, and Australia are leading the charge by encouraging the adoption of e-health technologies through the establishment of national health IT strategies and interoperability standards. These initiatives facilitate the exchange of electronic health records (EHRs) and other critical health information among healthcare institutions. Noteworthy examples include China’s Healthy China 2030 initiative and Australia’s My Health Record program.

Breakdown of Supply-side Primary Interviews, by Company Type, Designation, and Region:
? By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
? By Designation: C-level Executives (35%), Directors (45%), and Others (20%)
? By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%), and the Middle East & Africa (5%)
List of Companies Profiled in the Report
o Epic Systems Corporation (US)
o Oracle (US)
o InterSystems Corporation (US)
o Veradigm LLC (US)
o Medical Information Technology, Inc. (US)
o Health Catalyst (US)
o Chetu Inc. (US)
o Meditab (US)
o Siemens Healthineers (Germany)
o Deloitte (UK)
o Dreamsoft4u (US)
o NCrypted Technologies. (India)
o Glorium Technologies (US)
o Daffodil Unthinkable Software Corporation (US)
o eClinicalWorks (US)
o NXGN Management, LLC (US)
o Orion Health (New Zealand)
o Kellton (India)
o Telstra Health (Australia)
o CGI Inc. (Canada)
o Excelicare (US)
o Octal IT Solution (US)
o Andersen (Poland)
o SISGAIN (India)
o Cleverdev Software (US)
o OSP Labs (US)
Research Coverage
This report analyzes the healthcare information exchange market based on various factors, including type, setup type, implementation model, solution, component, application, end user, and region. It examines the drivers, opportunities, and challenges that influence market growth. Additionally, the report assesses the opportunities and challenges for stakeholders and details the competitive landscape for market leaders. The study also explores micro markets, focusing on their growth trends, prospects, and contributions to the overall health information exchange market. Furthermore, it provides revenue forecasts for the market segments across five major regions.

Reasons to Buy the Report
This report also includes.
? Analysis of key drivers (rising adoption of EHR/EMR solutions, growing focus on patient-centric care delivery, need to curtail escalating healthcare costs, government initiatives and regulations to enhance patient care and safety, and rising investments from government and private institutions), restraints (need for significant investments in infrastructure development and high cost of deployment, lack of true interoperability solutions, and use of outdated legacy systems), opportunities (improving healthcare infrastructure in emerging markets and advancements in software technology for real-time data exchange), and challenges (patient data security and privacy concerns in the healthcare industry, increasing complexity due to lack of consistent data, and shortage of skilled healthcare IT professionals) are contributing the growth of the healthcare information exchange market.
? Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the healthcare information exchange market.
? Market Development: Comprehensive information on the lucrative emerging markets, components, applications, end users, and regions.
? Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the healthcare information exchange market.
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global healthcare information exchange market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 30
1.3.2 INCLUSIONS & EXCLUSIONS OF STUDY 31
1.3.3 YEARS CONSIDERED 32
1.3.4 CURRENCY CONSIDERED 32
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 33
2 EXECUTIVE SUMMARY 34
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE INFORMATION EXCHANGE MARKET 36
2.4 HIGH-GROWTH SEGMENTS 37
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR HEALTHCARE INFORMATION EXCHANGE MARKET 39
3.2 NORTH AMERICA HEALTH INFORMATION EXCHANGE MARKET,
BY END USER AND COUNTRY 40
3.3 HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 42
4.2.1 DRIVERS 43
4.2.1.1 Rising adoption of EHR/EMR solutions 43
4.2.1.2 Growing focus on patient-centric care delivery 43
4.2.1.3 Need to curtail escalating healthcare costs 44
4.2.1.4 Government initiatives and regulations to enhance patient care & safety 45
4.2.1.5 Rising investments from government & private institutes 46
4.2.2 RESTRAINTS 47
4.2.2.1 Need for significant investments in infrastructure development and high cost of deployment 47
4.2.2.2 Lack of true interoperability solutions 47
4.2.2.3 Use of outdated legacy systems 48
?
4.2.3 OPPORTUNITIES 49
4.2.3.1 Improving healthcare infrastructure in emerging markets 49
4.2.3.2 Advancements in software technology for real-time data exchange 49
4.2.4 CHALLENGES 51
4.2.4.1 Patient data security and privacy concerns in healthcare industry 51
4.2.4.2 Increasing complexity due to lack of consistent data 52
4.2.4.3 Shortage of skilled healthcare IT professionals 52
4.3 UNMET NEEDS AND WHITE SPACES 53
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 54
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55
5 INDUSTRY TRENDS 56
5.1 PORTER’S FIVE FORCES ANALYSIS 56
5.1.1 BARGAINING POWER OF SUPPLIERS (MODERATE) 57
5.1.2 BARGAINING POWER OF BUYERS (HIGH) 57
5.1.3 THREAT OF SUBSTITUTES (LOW TO MODERATE) 57
5.1.4 THREAT OF NEW ENTRANTS (MODERATE) 58
5.1.5 INTENSITY OF COMPETITIVE RIVALRY (HIGH) 58
5.2 MACROECONOMIC INDICATORS 58
5.2.1 GDP TRENDS AND FORECAST 58
5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 59
5.3 VALUE CHAIN ANALYSIS 59
5.4 ECOSYSTEM ANALYSIS 61
5.5 PRICING ANALYSIS 64
5.5.1 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY TYPE, 2025 64
5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION, 2025 65
5.6 KEY CONFERENCES AND EVENTS, 2026?2027 65
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66
5.8 INVESTMENT AND FUNDING SCENARIO 67
5.9 CASE STUDY ANALYSIS 68
5.9.1 INTEROPERABILITY SOLUTIONS TO LEVERAGE CLINICAL WORKFLOWS 68
5.9.2 SHARING CLINICAL INFORMATION TO SET FOUNDATION OF EFFICIENT AND EFFECTIVE HEALTHCARE DELIVERY 68
5.9.3 SUPPORTING HEALTH INFORMATION EXCHANGE ACCESS 69
5.10 IMPACT OF 2025 US TARIFF 69
5.10.1 KEY TARIFF RATES 70
5.10.2 PRICE IMPACT ANALYSIS 71
5.10.3 IMPACT ON COUNTRY/REGION 71
5.10.3.1 US 71
5.10.3.2 Europe 72
5.10.3.3 Asia Pacific 72
?
5.10.4 IMPACT ON END-USE INDUSTRY 73
5.10.4.1 Healthcare Providers 73
5.10.4.2 Healthcare Payers 73
5.10.4.3 Pharmacies 73
5.10.4.4 Laboratories 73
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 74
6.1 KEY TECHNOLOGIES 74
6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 74
6.1.2 BLOCKCHAIN 75
6.2 COMPLEMENTARY TECHNOLOGIES 75
6.2.1 INTERNET OF THINGS 75
6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE TOOLS 75
6.3 ADJACENT TECHNOLOGIES 76
6.3.1 CLOUD COMPUTING 76
6.4 TECHNOLOGY/PRODUCT ROADMAP 76
6.5 PATENT ANALYSIS 77
6.5.1 PATENT PUBLICATION TRENDS FOR THE HEALTHCARE INFORMATION EXCHANGE MARKET 77
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 78
6.6 FUTURE APPLICATIONS 81
6.6.1 AI-DRIVEN PREDICTIVE CARE COORDINATION AND DECISION SUPPORT 82
6.6.2 UNIFIED LONGITUDINAL PATIENT RECORDS AND CONSUMER ACCESS 82
6.6.3 REAL-TIME PUBLIC HEALTH SURVEILLANCE AND EMERGENCY RESPONSE 82
6.6.4 BLOCKCHAIN-ENABLED TRUSTED DATA EXCHANGE 82
6.6.5 VALUE-BASED CARE, PAYER INTEGRATION, AND REVENUE OPTIMIZATION 82
6.6.6 INTEGRATION WITH REMOTE MONITORING, GENOMICS, AND PRECISION MEDICINE 82
6.7 IMPACT OF AI/GEN AI 83
6.7.1 MARKET POTENTIAL OF AI/GEN AI 84
6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 85
6.7.2.1 AI-Driven Clinical Summarization and Interoperability Intelligence at InterSystems HealthShare 85
6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 86
6.7.3.1 Healthcare data analytics and AI-driven interoperability platforms 86
6.7.3.2 Digital health platforms, integration, and regulatory infrastructure 86
6.7.3.3 Clinical care, payer operations, and personalized healthcare delivery 87
6.7.4 USER READINESS AND IMPACT ASSESSMENT 87
6.7.4.1 User readiness 87
6.7.4.1.1 User A: Healthcare Providers (Hospitals, Clinics, Long-Term Care Centers, Other Providers) 87
6.7.4.1.2 User B: Healthcare Payers 87
6.7.4.2 Impact assessment 88
6.7.4.2.1 User A: Healthcare Providers 88
6.7.4.2.1.1 Implementation 88
6.7.4.2.1.2 Impact 88
6.7.4.2.2 User B: Healthcare Payers 88
6.7.4.2.2.1 Implementation 88
6.7.4.2.2.2 Impact 88
7 REGULATORY LANDSCAPE 89
7.1 REGIONAL REGULATIONS AND COMPLIANCE 89
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
7.1.2 INDUSTRY STANDARDS 92
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 93
8.1 DECISION-MAKING PROCESS 93
8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 93
8.2.1 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS 94
8.2.2 BUYING CRITERIA 95
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96
8.4 UNMET NEEDS FROM END-USE INDUSTRIES 96
8.4.1 UNMET NEEDS 96
8.4.2 END-USER EXPECTATIONS 97
8.5 MARKET PROFITABILITY 98
9 HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION 99
9.1 INTRODUCTION 100
9.2 WEB PORTAL DEVELOPMENT 100
9.2.1 LARGE NUMBER OF PHYSICIANS OPTING FOR ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET 100
9.3 WORKFLOW MANAGEMENT 102
9.3.1 BETTER DECISION-MAKING FOR ENHANCED PATIENT CARE TO PROPEL MARKET 102
9.4 SECURE MESSAGING 103
9.4.1 ABILITY TO PROVIDE SECURE COMMUNICATION WITHIN AND OUTSIDE CARE NETWORK TO SUPPORT MARKET GROWTH 103
9.5 INTERNAL INTERFACING 105
9.5.1 FASTEST-GROWING APPLICATION SEGMENT DURING FORECAST PERIOD 105
9.6 TRANSACTION MONITORING 106
9.6.1 SECURE, EFFICIENT, AND COMPLIANT EXCHANGE OF HEALTH DATA?KEY FACTORS DRIVING MARKET GROWTH 106
?
10 HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT 108
10.1 INTRODUCTION 109
10.2 CLINICAL DATA REPOSITORY 109
10.2.1 EASY ACCESS TO DATA ACROSS EMR DOMAIN TO SUPPORT MARKET GROWTH 109
10.3 ENTERPRISE MASTER PERSON INDEX 110
10.3.1 EMPI TO DOMINATE HIE MARKET DURING FORECAST PERIOD 110
10.4 RECORD LOCATOR SERVICE 112
10.4.1 RLS TO REGISTER HIGHEST GROWTH RATE 112
10.5 HEALTHCARE PROVIDER DIRECTORY 113
10.5.1 COMPREHENSIVE DATABASE AND RELIABILITY OF HPD TO DRIVE MARKET 113
11 HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL 114
11.1 INTRODUCTION 115
11.2 HYBRID MODEL 115
11.2.1 HYBRID HIE MODELS TO HOLD LARGEST MARKET SHARE 115
11.3 CENTRALIZED MODEL 117
11.3.1 PRIVACY AND SECURITY CONCERNS TO HINDER ADOPTION OF
CENTRALIZED HIE 117
11.4 DECENTRALIZED/FEDERATED 118
11.4.1 REAL-TIME UPDATED DATA AVAILABILITY AND INCREASED
SECURITY TO DRIVE ADOPTION 118
12 HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE 120
12.1 INTRODUCTION 121
12.2 PRIVATE 121
12.2.1 RISING MANDATES FOR INCENTIVE PROGRAMS TO DRIVE MARKET 121
12.3 PUBLIC 123
12.3.1 GROWING GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH 123
13 HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION 126
13.1 INTRODUCTION 127
13.2 PORTAL-CENTRIC HIE SOLUTIONS 127
13.2.1 PORTAL-CENTRIC SOLUTIONS TO DOMINATE HEALTH INFORMATION EXCHANGE MARKET DURING FORECAST PERIOD 127
13.3 MESSAGING-CENTRIC HIE SOLUTIONS 128
13.3.1 HIGH PERFORMANCE AND RELIABILITY OF MESSAGING-CENTRIC SOLUTIONS TO DRIVE MARKET 128
13.4 PLATFORM-CENTRIC HIE SOLUTIONS 129
13.4.1 PLATFORM-CENTRIC SOLUTIONS TO REGISTER HIGHEST
GROWTH RATE DURING FORECAST PERIOD 129
?
14 HEALTH INFORMATION EXCHANGE MARKET, BY TYPE 131
14.1 INTRODUCTION 132
14.2 DIRECTED EXCHANGE 132
14.2.1 DIRECTED EXCHANGE SEGMENT TO COMMAND LARGEST SHARE
OF HEALTH INFORMATION EXCHANGE MARKET 132
14.3 QUERY-BASED EXCHANGE 134
14.3.1 QUERY-BASED EXCHANGE SEGMENT TO REGISTER HIGHEST
GROWTH RATE DURING FORECAST PERIOD 134
14.4 CONSUMER-MEDIATED EXCHANGE 135
14.4.1 GROWING PATIENT-PHYSICIAN INTERACTION TO DRIVE
POPULARITY OF CONSUMER-MEDIATED SOLUTIONS 135
15 HEALTH INFORMATION EXCHANGE MARKET, BY REGION 137
15.1 INTRODUCTION 138
15.2 NORTH AMERICA 138
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 139
15.2.2 US 144
15.2.2.1 Layered interoperability and stringent certification
requirements to drive market 144
15.2.3 CANADA 148
15.2.3.1 Government initiatives to support HIE adoption in Canada 148
15.3 EUROPE 152
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 153
15.3.2 GERMANY 157
15.3.2.1 Landmark Health Data Use Act and EHDS alignment catalyze research-grade HIE platforms 157
15.3.3 UK 161
15.3.3.1 Growing patient volumes to drive market 161
15.3.4 FRANCE 165
15.3.4.1 Favorable government initiatives to drive market 165
15.3.5 ITALY 169
15.3.5.1 PNRR-funded FSE 2.0 drives national interoperability and cross-regional HIE unification 169
15.3.6 SPAIN 174
15.3.6.1 Cross-regional HIE scale-up and national AI strategy
cement digital health leadership 174
15.3.7 REST OF EUROPE 177
15.4 ASIA PACIFIC 181
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 182
15.4.2 JAPAN 187
15.4.2.1 Growing need to digitize patient records to drive market 187
15.4.3 CHINA 191
15.4.3.1 Large patient population and healthcare infrastructure
improvements to drive market 191
15.4.4 INDIA 195
15.4.4.1 Rising need for cost-effective technologies to drive
HCIT integration in India 195
15.4.5 REST OF ASIA PACIFIC 200
15.5 LATIN AMERICA 204
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 204
15.5.2 BRAZIL 208
15.5.2.1 RNDS formalized as national interoperability backbone with 2.8 billion clinical records 208
15.5.3 MEXICO 213
15.5.3.1 openEHR Adoption and IMSS digital health
modernization drive national HIE platform investment 213
15.5.4 REST OF LATIN AMERICA 216
15.6 MIDDLE EAST & AFRICA 220
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 221
15.6.2 GCC COUNTRIES 224
15.6.2.1 Growing focus on implementing HCIT to drive market 224
15.6.3 REST OF MIDDLE EAST & AFRICA 228
16 COMPETITIVE LANDSCAPE 233
16.1 OVERVIEW 233
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023?2026 233
16.3 REVENUE ANALYSIS, 2021?2025 235
16.4 MARKET SHARE ANALYSIS, 2025 236
16.5 BRAND/SOFTWARE COMPARISON 239
16.6 COMPANY VALUATION & FINANCIAL METRICS 240
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 241
16.7.1 STARS 241
16.7.2 EMERGING LEADERS 241
16.7.3 PERVASIVE PLAYERS 241
16.7.4 PARTICIPANTS 241
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 243
16.7.5.1 Company footprint 243
16.7.5.2 Region footprint 244
16.7.5.3 Setup type footprint 245
16.7.5.4 End user footprint 246
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 247
16.8.1 PROGRESSIVE COMPANIES 247
16.8.2 RESPONSIVE COMPANIES 247
16.8.3 DYNAMIC COMPANIES 247
16.8.4 STARTING BLOCKS 247
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 249
?
16.9 COMPETITIVE SCENARIO 250
16.9.1 PRODUCT LAUNCHES 250
16.9.2 DEALS 251
17 COMPANY PROFILES 252
17.1 KEY PLAYERS 252
17.1.1 EPIC SYSTEMS CORPORATION. 252
17.1.1.1 Business overview 252
17.1.1.2 Products and Services offered 253
17.1.1.3 Recent developments 254
17.1.1.3.1 Product launches and approvals 254
17.1.1.3.2 Deals 254
17.1.1.4 MnM view 255
17.1.1.4.1 Right to win 255
17.1.1.4.2 Strategic choices 256
17.1.1.4.3 Weaknesses and competitive threats 256
17.1.2 ORACLE 257
17.1.2.1 Business overview 257
17.1.2.2 Products and services offered 258
17.1.2.3 Recent developments 259
17.1.2.3.1 Product launches and approvals 259
17.1.2.3.2 Deals 260
17.1.2.4 MnM view 261
17.1.2.4.1 Right to win 261
17.1.2.4.2 Strategic choices 261
17.1.2.4.3 Weaknesses and competitive threats 261
17.1.3 INTERSYSTEMS CORPORATION 263
17.1.3.1 Business overview 263
17.1.3.2 Products and services offered 264
17.1.3.3 Recent developments 265
17.1.3.3.1 Product launches and approvals 265
17.1.3.3.2 Deals 265
17.1.3.4 MnM view 265
17.1.3.4.1 Right to win 266
17.1.3.4.2 Strategic choices 266
17.1.3.4.3 Weaknesses and competitive threats 266
17.1.4 VERADIGM LLC 268
17.1.4.1 Business overview 268
17.1.4.2 Products and services offered 270
17.1.4.3 Recent developments 271
17.1.4.3.1 Product launches and approvals 271
17.1.4.3.2 Deals 271
17.1.4.4 MnM view 271
17.1.4.4.1 Right to win 271
17.1.4.4.2 Strategic choices 272
17.1.4.4.3 Weaknesses and competitive threats 272
17.1.5 MEDICAL INFORMATION TECHNOLOGY, INC. 273
17.1.5.1 Business overview 273
17.1.5.2 Products and services offered 274
17.1.5.3 Recent developments 275
17.1.5.3.1 Product launches and approvals 275
17.1.5.3.2 Deals 275
17.1.5.4 MnM view 276
17.1.5.4.1 Right to win 276
17.1.5.4.2 Strategic choices 276
17.1.5.4.3 Weaknesses and competitive threats 276
17.1.6 HEALTH CATALYST 278
17.1.6.1 Business overview 278
17.1.6.2 Products and services offered 280
17.1.6.3 Recent developments 280
17.1.6.3.1 Deals 280
17.1.7 KELLTON 282
17.1.7.1 Business overview 282
17.1.7.2 Products and services offered 283
17.1.7.3 Recent developments 284
17.1.7.3.1 Deal 284
17.1.8 ECLINICALWORKS 285
17.1.8.1 Business overview 285
17.1.8.2 Products and services offered 286
17.1.8.3 Recent developments 286
17.1.8.3.1 Product launches and approvals 286
17.1.8.3.2 Deal 287
17.1.9 NXGN MANAGEMENT, LLC. 288
17.1.9.1 Business overview 288
17.1.9.2 Products and services offered 288
17.1.10 ORION HEALTH GROUP OF COMPANIES 290
17.1.10.1 Business overview 290
17.1.10.2 Products and services offered 291
17.1.10.3 Recent developments 291
17.1.10.3.1 Deal 291
17.1.11 CHETU INC. 292
17.1.11.1 Business overview 292
17.1.11.2 Products and services offered 292
17.1.11.3 Recent developments 293
17.1.11.3.1 Deal 293
17.1.12 TELSTRA HEALTH (A SUBSIDIARY OF TELSTRA CORPORATION LTD.) 294
17.1.12.1 Business overview 294
17.1.12.2 Products and services offered 295
17.1.12.2.1 Deal 295
17.1.13 CGI INC. 296
17.1.13.1 Business overview 296
17.1.13.2 Products and services offered 297
17.1.13.3 Recent developments 298
17.1.13.3.1 Product launches and approvals 298
17.1.13.3.2 Deal 298
17.1.14 MEDITAB 299
17.1.14.1 Business overview 299
17.1.14.2 Products and services offered 300
17.1.15 DREAMSOFT4U 301
17.1.15.1 Business overview 301
17.1.15.2 Products and services offered 301
17.1.16 NCRYPTED TECHNOLOGIES 302
17.1.16.1 Business overview 302
17.1.16.2 Products and services offered 302
17.1.17 GLORIUM TECHNOLOGIES 303
17.1.17.1 Business overview 303
17.1.17.2 Products and services offered 303
17.1.18 DAFFODIL UNTHINKABLE SOFTWARE CORP. 305
17.1.18.1 Business overview 305
17.1.18.2 Products and services offered 306
17.1.19 SIEMENS HEALTHINEERS AG 307
17.1.19.1 Business overview 307
17.1.19.2 Products and services offered 308
17.1.19.2.1 Product launches and approvals 309
17.1.20 DELOITTE 311
17.1.20.1 Business overview 311
17.1.20.2 Products and services offered 312
17.1.20.3 Recent developments 312
17.1.20.3.1 Deals 312
17.1.21 EXCELICARE 313
17.1.21.1 Business overview 313
17.1.21.2 Products and services offered 314
?
17.2 OTHER PLAYERS 315
17.2.1 OCTAL IT SOLUTION 315
17.2.2 ANDERSEN INC. 316
17.2.3 SISGAIN 317
17.2.4 CLEVERDEV SOFTWARE 318
17.2.5 OSP LABS 319
18 RESEARCH METHODOLOGY 320
18.1 RESEARCH DATA 320
18.1.1 SECONDARY DATA 321
18.1.1.1 Key data from secondary sources 322
18.1.2 PRIMARY DATA 322
18.1.2.1 Key data from primary sources 324
18.1.2.2 Breakdown of primaries 324
18.1.2.3 Insights from primary experts 325
18.2 RESEARCH METHODOLOGY DESIGN 325
18.3 MARKET SIZE ESTIMATION 326
18.4 MARKET BREAKDOWN DATA TRIANGULATION 331
18.5 MARKET SHARE ESTIMATION 332
18.6 STUDY ASSUMPTIONS 332
18.7 RESEARCH LIMITATIONS 333
18.7.1 METHODOLOGY-RELATED LIMITATIONS 333
18.8 RISK ASSESSMENT 333
19 APPENDIX 334
19.1 DISCUSSION GUIDE 334
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 340
19.3 CUSTOMIZATION OPTIONS 342
19.4 RELATED REPORTS 342
19.5 AUTHOR DETAILS 343

ページTOPに戻る

List of Tables/Graphs

TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD 32
TABLE 2 IMPACT OF PORTER’S FIVE FORCES 57
TABLE 3 ROLE OF COMPANIES IN ECOSYSTEM 63
TABLE 4 INDICATIVE PRICES OF HEALTHCARE INFORMATION EXCHANGE MARKET,
BY PRODUCT, 2025 64
TABLE 5 INDICATIVE PRICES OF HEALTHCARE INFORMATION EXCHANGE MARKET,
BY REGION, 2025 65
TABLE 6 KEY CONFERENCES AND EVENTS, 2026?2027 66
TABLE 7 CASE 1: HEALTHINFONET, IN COLLABORATION WITH ORION HEALTH,
ENSURES RAPID DELIVERY OF HIE SERVICES TO MAINE PATIENTS AND HEALTHCARE PROVIDERS 68
TABLE 8 CASE 2: WIRRAL SETS UP CERNER-BASED INFO SHARING 68
TABLE 9 CASE 3: HIE SOLUTIONS ENABLE WELLSPRING NURSES TO GATHER PATIENT INFORMATION TO ENSURE CONTINUITY AND QUALITY OF CARE 69
TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES 70
TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE INFORMATION EXCHANGE MARKET 79
TABLE 12 HEALTHCARE INFORMATION EXCHANGE MARKET: LIST
OF PATENTS/PATENT APPLICATIONS 80
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 94
TABLE 19 KEY BUYING CRITERIA, BY END USER 95
TABLE 20 UNMET NEEDS IN HEALTHCARE INFORMATION EXCHANGE MARKET 97
TABLE 21 END-USER EXPECTATIONS IN HEALTHCARE INFORMATION EXCHANGE
PHARMA & BIOTECH MARKET 97
TABLE 22 HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 100
TABLE 23 HEALTH INFORMATION EXCHANGE MARKET FOR WEB PORTAL
DEVELOPMENT, BY COUNTRY, 2024?2031 (USD MILLION) 101
TABLE 24 EXAMPLES OF SOLUTIONS FOR WORKFLOW MANAGEMENT 102
TABLE 25 HEALTH INFORMATION EXCHANGE MARKET FOR WORKFLOW MANAGEMENT,
BY COUNTRY, 2024?2031 (USD MILLION) 103
TABLE 26 HEALTH INFORMATION EXCHANGE MARKET FOR SECURE MESSAGING,
BY COUNTRY, 2024?2031 (USD MILLION) 105
TABLE 27 HEALTH INFORMATION EXCHANGE MARKET FOR INTERNAL INTERFACING,
BY COUNTRY, 2024?2031 (USD MILLION) 106
TABLE 28 HEALTH INFORMATION EXCHANGE MARKET FOR TRANSACTION MONITORING,
BY COUNTRY, 2024?2031 (USD MILLION) 107
TABLE 29 HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 109
TABLE 30 HEALTH INFORMATION EXCHANGE MARKET FOR CLINICAL DATA REPOSITORY,
BY COUNTRY, 2024?2031 (USD MILLION) 110
TABLE 31 HEALTH INFORMATION EXCHANGE MARKET FOR ENTERPRISE MASTER PERSON INDEX, BY COUNTRY, 2024?2031 (USD MILLION) 111
TABLE 32 HEALTH INFORMATION EXCHANGE MARKET FOR RECORD LOCATOR SERVICE,
BY COUNTRY, 2024?2031 (USD MILLION) 112
TABLE 33 HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDER DIRECTORY, BY COUNTRY, 2024?2031 (USD MILLION) 113
TABLE 34 HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL,
2024?2031 (USD MILLION) 115
TABLE 35 HYBRID HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 116
TABLE 36 CENTRALIZED HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 118
TABLE 37 DECENTRALIZED/FEDERATED HEALTH INFORMATION EXCHANGE MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 119
TABLE 38 HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 121
TABLE 39 PRIVATE SETUP OFFERED BY MARKET PLAYERS 122
TABLE 40 PRIVATE HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 123
TABLE 41 PUBLIC SETUP OFFERED BY MARKET PLAYERS 124
TABLE 42 PUBLIC HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 125
TABLE 43 HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 127
TABLE 44 PORTAL-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 128
TABLE 45 MESSAGING-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 129
TABLE 46 PLATFORM-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 130
TABLE 47 HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024?2031 (USD MILLION) 132
TABLE 48 DIRECTED HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 133
TABLE 49 QUERY-BASED HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 135
TABLE 50 CONSUMER-MEDIATED HIE MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 136
TABLE 51 HEALTH INFORMATION EXCHANGE MARKET, BY REGION,
2024?2031 (USD MILLION) 138
TABLE 52 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 140
TABLE 53 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 140
TABLE 54 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SETUP TYPE, 2024?2031 (USD MILLION) 140
TABLE 55 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 141
TABLE 56 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024?2031 (USD MILLION) 141
TABLE 57 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 142
TABLE 58 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 142
TABLE 59 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024?2031 (USD MILLION) 143
TABLE 60 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 143
TABLE 61 US: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 145
TABLE 62 US: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 145
TABLE 63 US: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 146
TABLE 64 US: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 146
TABLE 65 US: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 147
TABLE 66 US: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 147
TABLE 67 US: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 148
TABLE 68 US: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 148
TABLE 69 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 149
TABLE 70 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 150
TABLE 71 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 150
TABLE 72 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 150
TABLE 73 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 151
TABLE 74 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 151
TABLE 75 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 152
TABLE 76 CANADA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 152
TABLE 77 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 153
TABLE 78 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 154
TABLE 79 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 154
TABLE 80 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 154
TABLE 81 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 155
TABLE 82 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 155
TABLE 83 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 156
TABLE 84 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 156
TABLE 85 INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 157
TABLE 86 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 158
TABLE 87 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 158
TABLE 88 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 158
TABLE 89 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 159
TABLE 90 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 159
TABLE 91 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 160
TABLE 92 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 160
TABLE 93 GERMANY: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 161
TABLE 94 UK: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 162
TABLE 95 UK: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 162
TABLE 96 UK: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 162
TABLE 97 UK: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 163
TABLE 98 UK: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 163
TABLE 99 UK: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 164
TABLE 100 UK: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 164
TABLE 101 UK: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024?2031 (USD MILLION) 165
TABLE 102 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 166
TABLE 103 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 166
TABLE 104 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 167
TABLE 105 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 167
TABLE 106 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 168
TABLE 107 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 168
TABLE 108 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 169
TABLE 109 FRANCE: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 169
TABLE 110 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 170
TABLE 111 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 170
TABLE 112 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 171
TABLE 113 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 171
TABLE 114 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 172
TABLE 115 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 172
TABLE 116 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 173
TABLE 117 ITALY: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 173
TABLE 118 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 119 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 175
TABLE 120 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 175
TABLE 121 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 175
TABLE 122 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 176
TABLE 123 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 176
TABLE 124 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 177
TABLE 125 SPAIN: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 177
TABLE 126 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 178
TABLE 127 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024?2031 (USD MILLION) 179
TABLE 128 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 179
TABLE 129 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024?2031 (USD MILLION) 179
TABLE 130 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 180
TABLE 131 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 180
TABLE 132 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024?2031 (USD MILLION) 181
TABLE 133 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 181
TABLE 134 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 183
TABLE 135 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 184
TABLE 136 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 184
TABLE 137 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 184
TABLE 138 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 185
TABLE 139 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 185
TABLE 140 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 186
TABLE 141 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 186
TABLE 142 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 187
TABLE 143 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 188
TABLE 144 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 188
TABLE 145 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 189
TABLE 146 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 189
TABLE 147 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 190
TABLE 148 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 190
TABLE 149 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 191
TABLE 150 JAPAN: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 191
TABLE 151 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 192
TABLE 152 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 193
TABLE 153 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 193
TABLE 154 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 193
TABLE 155 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 194
TABLE 156 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 194
TABLE 157 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 195
TABLE 158 CHINA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 195
TABLE 159 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 196
TABLE 160 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 196
TABLE 161 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 197
TABLE 162 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 198
TABLE 163 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 198
TABLE 164 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 199
TABLE 165 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 199
TABLE 166 INDIA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 200
TABLE 167 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 201
TABLE 168 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY SETUP TYPE, 2024?2031 (USD MILLION) 201
TABLE 169 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 201
TABLE 170 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY SOLUTION, 2024?2031 (USD MILLION) 202
TABLE 171 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 202
TABLE 172 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 203
TABLE 173 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET,
BY END USER, 2024?2031 (USD MILLION) 203
TABLE 174 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 175 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 205
TABLE 176 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 205
TABLE 177 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024?2031 (USD MILLION) 205
TABLE 178 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 206
TABLE 179 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024?2031 (USD MILLION) 206
TABLE 180 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 207
TABLE 181 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 207
TABLE 182 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024?2031 (USD MILLION) 208
TABLE 183 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 208
TABLE 184 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 209
TABLE 185 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 210
TABLE 186 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 210
TABLE 187 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 210
TABLE 188 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 211
TABLE 189 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 211
TABLE 190 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 212
TABLE 191 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 212
TABLE 192 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 213
TABLE 193 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE,
2024?2031 (USD MILLION) 214
TABLE 194 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 214
TABLE 195 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION,
2024?2031 (USD MILLION) 214
TABLE 196 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 215
TABLE 197 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 215
TABLE 198 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY END USER,
2024?2031 (USD MILLION) 216
TABLE 199 MEXICO: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 216
TABLE 200 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 217
TABLE 201 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SETUP TYPE, 2024?2031 (USD MILLION) 217
TABLE 202 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 218
TABLE 203 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SOLUTION, 2024?2031 (USD MILLION) 218
TABLE 204 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 219
TABLE 205 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 219
TABLE 206 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET,
BY END USER, 2024?2031 (USD MILLION) 220
TABLE 207 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 208 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY REGION, 2024?2031 (USD MILLION) 221
TABLE 209 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 221
TABLE 210 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SETUP TYPE, 2024?2031 (USD MILLION) 222
TABLE 211 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 222
TABLE 212 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SOLUTION, 2024?2031 (USD MILLION) 222
TABLE 213 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 223
TABLE 214 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 223
TABLE 215 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY END USER, 2024?2031 (USD MILLION) 224
TABLE 216 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 217 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE,
2024?2031 (USD MILLION) 225
TABLE 218 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024?2031 (USD MILLION) 226
TABLE 219 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 226
TABLE 220 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024?2031 (USD MILLION) 226
TABLE 221 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 227
TABLE 222 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 227
TABLE 223 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024?2031 (USD MILLION) 228
TABLE 224 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 228
TABLE 225 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 229
TABLE 226 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SETUP TYPE, 2024?2031 (USD MILLION) 230
TABLE 227 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY IMPLEMENTATION MODEL, 2024?2031 (USD MILLION) 230
TABLE 228 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY SOLUTION, 2024?2031 (USD MILLION) 230
TABLE 229 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 231
TABLE 230 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 231
TABLE 231 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET,
BY END USER, 2024?2031 (USD MILLION) 232
TABLE 232 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET
FOR HEALTHCARE PROVIDERS, BY TYPE, 2024?2031 (USD MILLION) 232
TABLE 233 STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE INFORMATION EXCHANGE MARKET, JANUARY 2023?MAY 2026 233
TABLE 234 HEALTHCARE INFORMATION EXCHANGE MARKET: DEGREE OF COMPETITION 237
TABLE 235 HEALTH INFORMATION EXCHANGE MARKET: REGION FOOTPRINT 244
TABLE 236 HEALTH INFORMATION EXCHANGE MARKET: SETUP TYPE FOOTPRINT 245
TABLE 237 HEALTH INFORMATION EXCHANGE MARKET: END USER FOOTPRINT 246
TABLE 238 HEALTH INFORMATION EXCHANGE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 249
TABLE 239 HEALTH INFORMATION EXCHANGE MARKET: COMPETITIVE
BENCHMARKING OF KEY STARTUPS/SMES 250
TABLE 240 HEALTH INFORMATION EXCHANGE MARKET: PRODUCT LAUNCHES, JANUARY 2023?MAY 2026 250
TABLE 241 HEALTH INFORMATION EXCHANGE MARKET: DEALS, JANUARY 2023?MAY 2026 251
TABLE 242 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 253
TABLE 243 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 253
TABLE 244 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023?MAY 2026 254
TABLE 245 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023?MAY 2026 254
TABLE 246 ORACLE: BUSINESS OVERVIEW 257
TABLE 247 ORACLE: PRODUCTS OFFERED 258
TABLE 248 ORACLE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023?MAY 2026 259
TABLE 249 ORACLE: DEALS, JANUARY 2022?MAY 2026 260
TABLE 250 INTERSYSTEMS CORPORATION: BUSINESS OVERVIEW 264
TABLE 251 INTERSYSTEMS CORPORATION: PRODUCTS OFFERED 264
TABLE 252 INTERSYSTEMS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023?MAY 2026 265
TABLE 253 INTERSYSTEMS CORPORATION: DEALS, JANUARY 2022?MAY 2026 265
TABLE 254 VERADIGM LLC: BUSINESS OVERVIEW 269
TABLE 255 VERADIGM LLC: PRODUCTS OFFERED 270
TABLE 256 VERADIGM LLC: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023?MAY 2026 271
TABLE 257 VERADIGM LLC: DEALS, JANUARY 2022?MAY 2026 271
TABLE 258 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW 274
TABLE 259 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED 274
TABLE 260 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023?MAY 2026 275
TABLE 261 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022?MAY 2026 275
TABLE 262 HEALTH CATALYST: BUSINESS OVERVIEW 279
TABLE 263 HEALTH CATALYST: PRODUCTS OFFERED 280
TABLE 264 HEALTH CATALYST: DEALS, JANUARY 2023?MAY 2026 280
TABLE 265 KELLTON: BUSINESS OVERVIEW 282
TABLE 266 KELLTON: PRODUCTS OFFERED 283
TABLE 267 KELLTON: DEALS, JANUARY 2023?MAY 2026 284
TABLE 268 ECLINICALWORKS: BUSINESS OVERVIEW 285
TABLE 269 ECLINICALWORKS: PRODUCTS OFFERED 286
TABLE 270 ECLINICALWORKS: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023?MAY 2026 286
TABLE 271 ECLINICALWORKS: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 287
TABLE 272 NXGN MANAGEMENT, LLC. : BUSINESS OVERVIEW 288
TABLE 273 NXGN MANAGEMENT, LLC.: PRODUCTS OFFERED 288
TABLE 274 ORION HEALTH GROUP OF COMPANIES: BUSINESS OVERVIEW 290
TABLE 275 ORION HEALTH GROUP OF COMPANIES: PRODUCTS OFFERED 291
TABLE 276 ORION HEALTH GROUP OF COMPANIES: OTHER DEVELOPMENTS,
JANUARY 2023?MAY 2026 291
TABLE 277 CHETU INC.: BUSINESS OVERVIEW 292
TABLE 278 CHETU INC.: PRODUCTS OFFERED 292
TABLE 279 CHETU INC.: DEALS, JANUARY 2023?MAY 2026 293
TABLE 280 TELSTRA HEALTH: BUSINESS OVERVIEW 294
TABLE 281 TELSTRA HEALTH: PRODUCTS OFFERED 295
TABLE 282 TELSTRA HEALTH: DEALS, JANUARY 2023?MAY 2026 295
TABLE 283 CGI INC.: BUSINESS OVERVIEW 296
TABLE 284 CGI INC.: PRODUCTS OFFERED 297
TABLE 285 CGI INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023?MAY 2026 298
TABLE 286 CGI INC.: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 298
TABLE 287 MEDITAB: BUSINESS OVERVIEW 299
TABLE 288 MEDITAB: PRODUCTS OFFERED 300
TABLE 289 DREAMSOFT4U: BUSINESS OVERVIEW 301
TABLE 290 DREAMSOFT4U: PRODUCTS OFFERED 301
TABLE 291 NCRYPTED TECHNOLOGIES.: BUSINESS OVERVIEW 302
TABLE 292 NCRYPTED TECHNOLOGIES: PRODUCTS OFFERED 302
TABLE 293 GLORIUM TECHNOLOGIES: BUSINESS OVERVIEW 303
TABLE 294 GLORIUM TECHNOLOGIES: PRODUCTS OFFERED 303
TABLE 295 DAFFODIL UNTHINKABLE SOFTWARE CORP.: BUSINESS OVERVIEW 305
TABLE 296 DAFFODIL UNTHINKABLE SOFTWARE CORP.: PRODUCTS AND SERVICES OFFERED 306
TABLE 297 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 307
TABLE 298 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 308
TABLE 299 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023?MAY 2026 309
TABLE 300 DELOITTE: BUSINESS OVERVIEW 311
TABLE 301 DELOITTE: PRODUCTS OFFERED 312
TABLE 302 DELOITTE: DEALS, JANUARY 2022?MAY 2026 312
TABLE 303 EXCELICARE: BUSINESS OVERVIEW 313
TABLE 304 EXCELICARE: PRODUCTS OFFERED 314
TABLE 305 RISK ASSESSMENT: HEALTHCARE INFORMATION EXCHANGE (HIE) MARKET 333FIGURE 1 MARKET SCENARIO 34
FIGURE 2 GLOBAL HEALTHCARE INFORMATION EXCHANGE MARKET, 2024?2031 35
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE
INFORMATION EXCHANGE MARKET 35
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE
INFORMATION EXCHANGE MARKET 36
FIGURE 5 HIGH-GROWTH SEGMENTS IN HEALTHCARE INFORMATION EXCHANGE MARKET 37
FIGURE 6 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 38
FIGURE 7 EXPANSION OF INTEROPERABLE DIGITAL HEALTH ECOSYSTEMS AND REAL-TIME CLINICAL DATA EXCHANGE FUEL DEMAND 39
FIGURE 8 HEALTHCARE PROVIDERS AND US ACCOUNTED FOR LARGEST SHARE IN 2025 40
FIGURE 9 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 41
FIGURE 10 US: NUMBER OF DATA COMPROMISES (2021?2025) 51
FIGURE 11 PORTER’S FIVE FORCES ANALYSIS 56
FIGURE 12 HEALTH INFORMATION EXCHANGE MARKET VALUE CHAIN ANALYSIS (2025) 60
FIGURE 13 ECOSYSTEM ANALYSIS 62
FIGURE 14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 67
FIGURE 16 PATENT PUBLICATION TRENDS IN HEALTHCARE INFORMATION EXCHANGE MARKET, 2015?2026 78
FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE INFORMATION EXCHANGE MARKET 78
FIGURE 18 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE INFORMATION EXCHANGE MARKET (JANUARY 2015 TO FEBRUARY 2026) 79
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 94
FIGURE 20 KEY BUYING CRITERIA, BY END USER 95
FIGURE 21 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET SNAPSHOT 139
FIGURE 22 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET SNAPSHOT 183
FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTH INFORMATION
EXCHANGE MARKET (2021?2025) 235
FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 236
FIGURE 25 HEALTH INFORMATION EXCHANGE MARKET: BRAND/SOFTWARE
COMPARATIVE ANALYSIS 239
FIGURE 26 EV/EBITDA OF KEY VENDORS 240
FIGURE 27 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK
BETA OF KEY VENDORS 240
FIGURE 28 HEALTH INFORMATION EXCHANGE MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 242
FIGURE 29 HEALTH INFORMATION EXCHANGE MARKET: COMPANY FOOTPRINT 243
FIGURE 30 HEALTH INFORMATION EXCHANGE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 248
FIGURE 31 ORACLE: COMPANY SNAPSHOT (2024) 258
FIGURE 32 VERADIGM LLC: COMPANY SNAPSHOT (2022) 269
FIGURE 33 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 279
FIGURE 34 KELLTON: COMPANY SNAPSHOT (2025) 283
FIGURE 35 CGI INC.: COMPANY SNAPSHOT (2025) 297
FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 308
FIGURE 37 RESEARCH DESIGN 320
FIGURE 38 PRIMARY SOURCES 323
FIGURE 39 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 324
FIGURE 40 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 326
FIGURE 41 BOTTOM-UP APPROACH 327
FIGURE 42 TOP-DOWN APPROACH 328
FIGURE 43 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS OF
HEALTHCARE INFORMATION EXCHANGE 329
FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 329
FIGURE 45 DATA TRIANGULATION METHODOLOGY 331